NMN vs NR: which is better for NAD+ and healthy aging?

NMN vs NR summarized

Conclusion in one sentence: both NAD+ precursors can increase circulating NAD+ levels, but current human evidence does not point to a universal winner.

What is NAD+ and why is it being researched?

NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme present in human cells that plays a central role in metabolism. NAD+ accepts electrons and releases them again during reactions through which cells process nutrients.

NAD+ is involved in, among other things:

• oxidation and reduction reactions related to energy metabolism;
• the functioning of enzymes such as sirtuins and PARP enzymes;
• cellular signaling processes;
• processes surrounding the maintenance and processing of DNA damage;
• the interaction between mitochondria, metabolism, and cellular stress responses.

Research describes age-related changes in NAD+ metabolism and lower NAD+ levels in certain tissues or groups. This pattern is not the same in every tissue and for every person. Therefore, scientists are researching substances that can serve as building blocks for NAD+.

NMN and NR are such NAD+ precursors. However, a higher NAD+ level is a biomarker. It is not automatic proof of more noticeable energy, a longer lifespan, or the prevention of disease.

For more background, read how NAD+, mitochondria, and other cellular processes are linked to healthy aging.

NMN vs nicotinamide riboside: what is the main difference?

NMN and NR are related molecules within vitamin B3 and NAD+ metabolism, but they are not the same. NMN contains a phosphate group that NR does not have. This structural difference determines which enzymatic step is required before the molecule can be converted into NAD+ in the simplified intracellular pathway.

What is NMN?

NMN stands for nicotinamide mononucleotide. Within cellular biosynthesis, NMN can be converted into NAD+ by NMNAT enzymes.

Simplified: NMN → NAD+

What is NR?

NR stands for nicotinamide riboside. In cells, NR is phosphorylated to NMN by nicotinamide riboside kinases, including NRK1 and NRK2. After that, NMN can be converted into NAD+ by NMNAT.

Simplified: NR → NMN → NAD+

Therefore, NMN is often described as the direct precursor of NAD+. The conclusion that NMN automatically works faster or better than NR because of this is too simple. A shorter route in a diagram does not say enough about what happens after oral intake in the gut, bloodstream, and various tissues.

Also read what NMN is and how NMN and NAD+ are biochemically related.

NMN and NR follow different conversion pathways to NAD+, but research has not yet identified a clear winner.

How are NMN and NR absorbed and converted?

The route after oral intake is more complex than the well-known arrows NMN → NAD+ and NR → NMN → NAD+ suggest. Part of NMN and NR can be converted into other NAD+ metabolites, including nicotinamide (NAM) and nicotinic acid (NA), before or during absorption. Subsequently, various biosynthetic pathways can contribute to the final formation of NAD+.

The salvage pathway

In the salvage pathway, the body recycles nicotinamide and related compounds to form new NAD+. NR can be converted into NMN via NRK enzymes. Nicotinamide can be reprocessed into NMN via NAMPT. NMNAT enzymes ultimately convert NMN into NAD+.

The role of the gut microbiota

The direct human comparison from 2026 supports a model in which gut microorganisms partially convert NMN and NR into nicotinic acid. That nicotinic acid can then contribute to circulating NAD+ via the Preiss-Handler pathway. This research makes it clear why “one step closer to NAD+” is not the same as “proven more effective after intake.”

The precise contribution of each pathway may depend on factors such as dosage, timing of measurement, gut microbiota, enzyme activity, and the tissue studied. Furthermore, blood levels do not automatically tell you what is happening in every organ.

What does direct comparative research on NMN vs NR show?

A randomized, open-label, and placebo-controlled study from 2026 compared NMN, NR, nicotinamide, and placebo directly in humans. In the modified intention-to-treat analysis, 65 healthy participants were included. After fourteen days, both NMN and NR increased circulating NAD+ concentrations to a similar extent; nicotinamide did not do so in the same sustained manner in this study.

View the direct human comparison via PubMed.

This study is important because individual NMN and NR studies are difficult to compare due to differences in dosage, target group, and measurement method. At the same time, this research has limitations:

• the intervention lasted only fourteen days;
• the study was open-label;
• the groups were relatively small;
• the primary outcome was circulating NAD+ and not a clinical health benefit;
• long-term safety, disease prevention, and lifespan were not investigated;
• several authors were employed by Nestlé Research or Nestlé Health Science.

The correct conclusion: this study shows that NMN and NR can both increase circulating NAD+ in the short term and found no clear winner. It does not prove that both substances have the same effects in the long term.

What does human research say about NMN?

The number of human studies on NMN has increased in recent years. The studies vary greatly in participants, daily amount, product formulation, duration, and measured outcomes.

In a double-blind, placebo-controlled study, thirty healthy adults took 250 mg of NMN or a placebo daily for twelve weeks. In the NMN group, the NAD+ concentration in whole blood increased. Within this study duration, no clear serious safety issues were reported.

View the NMN research in healthy adults via PubMed.

Another randomized study in older men also reported higher NAD+ levels and NAD+ metabolites after 250 mg of NMN per day.

View the study in older men via PubMed.

Not every functional outcome improves. In a study of sixty older adults, there was no significant difference in the primary stepping test after twelve weeks. Differences were reported in some secondary outcomes, including four-meter gait speed, NAD+ levels, and certain sleep questionnaires. Secondary outcomes require extra caution when the pre-selected primary outcome is not significant.

View the study on NMN, exercise, and sleep via PubMed.

These studies therefore primarily show that NMN can influence NAD+ metabolism. They do not prove that NMN stops aging, prevents diseases, extends human lifespan, or gives every user noticeably more energy.

For a broader overview, view the page 12 things about how NMN works.

What does human research say about nicotinamide riboside?

NR has a longer history in human supplementation studies than NMN. Various studies show that NR can increase NAD+ concentration or NAD+-related metabolites.

In a randomized study among healthy overweight adults, NR increased the NAD+ concentration in whole blood in a dose-dependent manner. Participants took 100, 300, or 1,000 mg of NR daily, or a placebo, for eight weeks.

View the dose-response study on NR via PubMed.

Earlier pharmacokinetic research with 100, 300, and 1,000 mg also showed that oral NR intake influences NAD+ metabolism in the blood.

View the pharmacokinetic NR study via PubMed.

Results for broader health outcomes are mixed. In a placebo-controlled study in men with obesity and insulin resistance, for example, NR did not significantly improve insulin sensitivity.

View the NR study on insulin sensitivity via PubMed.

So for NR too: a change in a biomarker is not the same as a proven clinical benefit.

NMN vs NR: which increases NAD+ better?

Based on the available human evidence, it cannot be generally stated that NMN or NR increases NAD+ better. For both, there are studies in which NAD+ levels or NAD+-related metabolites increase. The direct study from 2026 found a comparable increase in circulating NAD+ after fourteen days.

Comparing individual studies remains difficult because researchers make different choices regarding:

• the daily amount and product formulation;
• age, health, and group size of participants;
• the duration of the intervention;
• fasting or non-fasting measurements;
• whole blood, plasma, muscle tissue, or other measurement materials;
• the analysis method used;
• primary and secondary outcome measures.

An NMN study with 250 mg per day can therefore not be compared one-on-one with an NR study with 1,000 mg per day. Also, a higher blood level does not automatically say which substance yields more NAD+ in a specific tissue.

NMN or NR for healthy aging?

NMN and NR are scientifically interesting because NAD+ is involved in metabolism and cellular functions that can change during aging. This makes research into NAD+ precursors relevant, but neither substance has been proven in humans as a means of slowing down aging or extending lifespan.

A systematic review of human studies from 2026 concludes in broad terms that oral NMN and NR often show biochemical activity, while effects on functioning, metabolism, and other health outcomes are variable or often not convincing.

View the systematic review via PubMed.

For healthy aging, exercise, muscle strength, sleep, a varied diet, not smoking, social connection, and appropriate medical care remain the foundation. NMN or NR can at most be considered as a supplement to that foundation.

Also read the central guide on supplements for healthy aging.

What is the EU status of NMN and NR?

EU regulations distinguish between specific substances and product forms. Therefore, avoid the general statement that “NR is approved” or that the status of every NMN product is the same.

Nicotinamide riboside chloride

Nicotinamide riboside chloride is authorized as a novel food for certain applications and under established conditions of use. The EU regulation mentions a maximum of 300 mg per day for adults for food supplements, with the exception of pregnant and breastfeeding women; for those two groups, 230 mg per day is mentioned. Later amendments expanded authorized applications and conditions. This applies to the described substance that meets the specifications, not automatically to every conceivable form of NR.

View Implementing Regulation (EU) 2020/16 via EUR-Lex.

β-NMN

The European Commission publishes ongoing novel food applications for β-NMN. A submitted or ongoing application is not the same as inclusion in the Union list of authorized novel foods. Because dossiers and conditions can change, check the official Union list, the European Commission, and if necessary, the competent national authority for an up-to-date assessment.

Check the current EU list of authorized novel foods.

Note: this is general information and not legal advice. The legal assessment may depend on the exact substance, product specification, origin, application, labeling, and market.

NMN vs NR: which one fits you best?

The choice should therefore not rest solely on the argument that NMN is one step closer to NAD+. Also look at the exact product form, reliable certificates of analysis, labeling, regulations, price per amount used, and your own preference.

Can you combine NMN and NR?

NMN and NR ultimately come together in overlapping NAD+ pathways. There is currently insufficient human evidence that combining both substances provides a greater health benefit than using a single precursor.

A combination can also:

• increase the total amount of NAD+ precursors;
• make the routine more expensive and complex;
• make it harder to assess what you are responding to;
• increase the chance of unwanted effects or interactions.

For most users, one clearly formulated product is more practical. Follow the recommended amount on the label and consult a doctor or pharmacist if in doubt.

Safety and possible side effects

NMN and NR were generally well tolerated in several short-term human studies. That does not mean that every amount is proven safe for every user or for years of use.

The available studies often have:

• a limited group size;
• a duration of several weeks or months;
• specific inclusion and exclusion criteria;
• a product and dosage that are not identical to every commercial supplement.

Gastrointestinal complaints, headaches, or other individual reactions may occur. Stop in case of serious or persistent complaints and consult a doctor or pharmacist.

Seek professional advice before use if you:

• use medications;
• are pregnant or breastfeeding;
• have a liver or kidney condition;
• are under treatment for a chronic illness;
• combine multiple supplements;
• want to use NMN or NR for a medical complaint.

Read more about NMN side effects and safety and view the package leaflet for nicotinamide mononucleotide.

Buying NMN or NR: also check product quality

The choice of molecule is only one part of the equation. The identity, purity, and safety of the specific supplement are at least as relevant.

Check for an NMN or NR product:

• the exact name and form of the active substance;
• the amount per capsule or recommended serving;
• the full list of ingredients and excipients;
• batch number, shelf life, and storage advice;
• a certificate of analysis belonging to the batch sold;
• the analysis method used for identity and purity, for example HPLC;
• tests for heavy metals and microbiological contamination;
• the name and contact details of the responsible company;
• realistic communication without unproven medical claims.

Every Day Better publishes information on independent analyses and batch documents. See for yourself which test, measurement value, and batch belong to your product on the page about NMN certificates and quality control.

Choosing NMN at Every Day Better

Every Day Better offers NMN and not NR. However, available science shows that NR can also increase circulating NAD+ levels. Therefore, do not choose NMN based on the unproven claim that it always works better, but based on your preference for the ingredient, the product form, the available quality information, and ease of use.

NMN capsules: fixed amount per capsule

• NMN capsules 120 × 250 mg – larger pack with 250 mg NMN per capsule.
• NMN capsules 60 × 250 mg – more compact pack with 250 mg NMN per capsule.

NMN powder: flexible measurement

• NMN powder 30 grams – larger powder packaging.
• NMN powder 15 grams – smaller powder package.
• NMN powder and capsules bundle – powder for flexible measurement and capsules for a fixed amount.

Also view the guide on buying NMN, compare criteria for the best NMN supplement for your preference, or view all products.

Want to understand how NMN relates to other pathways? Then read the explanation of cellular energy, repair, and balance. TMG and GlyNAC have different compositions and functions than NAD+ precursors and are not substitutes for NMN or NR.

Frequently asked questions about NMN vs NR

Is NMN better than NR?

That has not been convincingly demonstrated. NMN is the direct precursor of NAD+ in the simplified cellular pathway, but this does not prove better absorption or better health effects. A direct human comparison from 2026 found a comparable increase in circulating NAD+ from NMN and NR after fourteen days.

What is the biggest difference between NMN and NR?

NMN contains a phosphate group and NR does not. In cells, NR is first converted into NMN by NRK enzymes. NMN can then be converted into NAD+ by NMNAT enzymes.

Do NMN and NR both increase NAD+?

Yes. Various human studies show that both NMN and NR can increase circulating NAD+ levels or NAD+-related metabolites. The magnitude of the change depends, among other things, on the amount, duration, participants, and measurement method.

Does more NAD+ automatically mean more energy?

No. A higher measured NAD+ concentration is a biochemical change. This does not automatically mean that every user feels more energetic or that a clinically relevant health benefit arises.

Is NMN better because it is one step closer to NAD+?

Not necessarily. The shorter intracellular pathway says insufficient about absorption, conversion by the gut microbiota, bioavailability, distribution across tissues, and final health effects after oral intake.

Which substance has been studied in humans longer?

NR has a longer history in human supplementation studies. However, the number of clinical studies on NMN has clearly increased in recent years.

Can you use NMN and NR at the same time?

That is theoretically possible, but there is insufficient evidence that the combination provides more benefit in healthy people than a single NAD+ precursor. The combination does increase total intake and makes the routine more complex.

Does NMN or NR extend human lifespan?

No. For neither substance has it been shown that supplementation extends human lifespan.

What is the difference between NR and vitamin B3?

NR is a vitamin B3-related compound and a precursor in NAD+ metabolism. It is not the same molecule as nicotinic acid or nicotinamide. These substances can contribute to the formation of NAD+ via different enzymatic pathways.

What NMN dosage is used in research?

Human studies use different amounts and study durations; 250 mg per day appears in several studies, but other amounts have also been investigated. A research dosage is not personal advice. Follow the label and read the detailed explanation of NMN dosage.

Are NMN and NR medicines?

No. Dietary supplements are not intended to diagnose, treat, cure, or prevent diseases.

Conclusion: Choosing NMN or NR?

The comparison NMN vs NR has no universal winner based on current human evidence.

• NMN and NR are both NAD+ precursors.
• NMN contains a phosphate group; NR is first converted into NMN in cells.
• The shorter route of NMN does not prove better absorption or effect.
• Both substances can increase circulating NAD+ levels.
• A direct short-term study from 2026 found a comparable NAD+ increase from NMN and NR.
• Effects on noticeable energy, healthy aging, and other clinical outcomes have not been consistently demonstrated.
• Lifespan extension in humans has not been proven for either.

Therefore, choose based on reliable product information, current regulations, independent quality control, ease of use, and your personal situation.

See which NMN form suits you

Scientific and official sources

1. Christen S, et al. Direct comparison of NMN, NR, and nicotinamide in healthy participants. Nature Metabolism, 2026. PubMed.
2. Okabe K, et al. NMN and NAD+ levels in healthy adults. Frontiers in Nutrition, 2022. PubMed.
3. Igarashi M, et al. NMN and NAD+ metabolites in older men. npj Aging, 2022. PubMed.
4. Morifuji M, et al. NMN, physical outcomes, NAD+, and sleep in older adults. GeroScience, 2024. PubMed.
5. Conze D, et al. Dose-dependent increase in NAD+ after NR intake. Scientific Reports, 2019. PubMed.
6. Trammell SAJ, et al. Human pharmacokinetics and NAD+ metabolism after NR intake. Nature Communications, 2016. PubMed.
7. Dollerup OL, et al. NR, safety, and insulin sensitivity in men with obesity. American Journal of Clinical Nutrition, 2018. PubMed.
8. Systematic review of human NAD+ interventions, 2026. PubMed.
9. European Commission. Implementing Regulation (EU) 2020/16 on nicotinamide riboside chloride. EUR-Lex.
10. European Commission. Union list of authorized novel foods. European Commission.